Suboptimal response for AL amyloidosis : is it time for early switch? Experience from a single amyloid program
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis - 29(2022), 3 vom: 26. Sept., Seite 208-209 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Puckrin, Robert [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.09.2022 Date Revised 15.11.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/13506129.2022.2055459 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338716017 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338716017 | ||
| 003 | DE-627 | ||
| 005 | 20231226001308.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/13506129.2022.2055459 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1129.xml |
| 035 | |a (DE-627)NLM338716017 | ||
| 035 | |a (NLM)35341414 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Puckrin, Robert |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Suboptimal response for AL amyloidosis |b is it time for early switch? Experience from a single amyloid program |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.09.2022 | ||
| 500 | |a Date Revised 15.11.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Amyloid |2 NLM | |
| 650 | 7 | |a Amyloidogenic Proteins |2 NLM | |
| 700 | 1 | |a Lee, Holly |e verfasserin |4 aut | |
| 700 | 1 | |a Tay, Jason |e verfasserin |4 aut | |
| 700 | 1 | |a Duggan, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a McCulloch, Sylvia |e verfasserin |4 aut | |
| 700 | 1 | |a Neri, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Bahlis, Nizar |e verfasserin |4 aut | |
| 700 | 1 | |a Jimenez-Zepeda, Victor H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis |d 1998 |g 29(2022), 3 vom: 26. Sept., Seite 208-209 |w (DE-627)NLM093771495 |x 1744-2818 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2022 |g number:3 |g day:26 |g month:09 |g pages:208-209 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/13506129.2022.2055459 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2022 |e 3 |b 26 |c 09 |h 208-209 | ||